Abstract

Autism spectrum disorder (ASD) is a highly prevalent neurodevelopmental disorder that exhibits a common set of behavioral and cognitive impairments. Although the etiology of ASD remains unclear, mitochondrial dysfunction has recently emerged as a possible causative factor underlying ASD. The ketogenic diet (KD) is a high-fat, low-carbohydrate diet that augments mitochondrial function, and has been shown to reduce autistic behaviors in both humans and in rodent models of ASD. The aim of the current study was to examine mitochondrial bioenergetics in the BTBR mouse model of ASD and to determine whether the KD improves mitochondrial function. We also investigated changes in mitochondrial morphology, which can directly influence mitochondrial function. We found that BTBR mice had altered mitochondrial function and exhibited smaller more fragmented mitochondria compared to C57BL/6J controls, and that supplementation with the KD improved both mitochondrial function and morphology. We also identified activating phosphorylation of two fission proteins, pDRP1S616 and pMFFS146, in BTBR mice, consistent with the increased mitochondrial fragmentation that we observed. Intriguingly, we found that the KD decreased pDRP1S616 levels in BTBR mice, likely contributing to the restoration of mitochondrial morphology. Overall, these data suggest that impaired mitochondrial bioenergetics and mitochondrial fragmentation may contribute to the etiology of ASD and that these alterations can be reversed with KD treatment.

Highlights

  • Autism is a complex, heterogeneous neurodevelopmental disorder characterized by abnormal social interactions, communication deficits, and repetitive movements [1,2,3,4]

  • Our results indicate evidence correlating mitochondrial dysfunction with autism spectrum disorder (ASD) and improved mitochondrial function following treatment with the ketogenic diet (KD)

  • We demonstrated that the KD improves mitochondrial function and uncovered potential pathways through which the KD may alter brain mitochondrial morphology in BTBR mice

Read more

Summary

Introduction

Heterogeneous neurodevelopmental disorder characterized by abnormal social interactions, communication deficits, and repetitive movements [1,2,3,4]. A recent study suggested a 2.5% prevalence of autism spectrum disorder (ASD) in the United States [5]. While the etiology of ASD remains unknown, it is likely that a combination of genetic, epigenetic, and environmental risk factors are involved [6]. Many children with ASD present with medical comorbidities, such as epilepsy [7], gastrointestinal (GI) abnormalities [8], and mitochondrial disease [2,9,10,11,12]. Estimates suggest that 5–80% of ASD patients exhibit markers of mitochondrial dysfunction [16]. Toxins linked to ASD inhibit mitochondrial function [19,20]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call